The overall objective of SCANHEALTH is the optimization, experimental validation, and CE marking of an effective, accurate, minimally invasive, and cost-efficient methodology for the early detection of multiple types of cancer (colorectal, breast, and lung cancer) through a single liquid biopsy analysis.
Coordinator: Amber Health Solutions S.L.
Website: https://www.amberhs.com/proyectos/
Period: 01/12/2025 – 30/11/2028
